1. Mechanistic insights into the benefits of multisite pacing in cardiac resynchronization therapy: The importance of electrical substrate and rate of left ventricular activation
- Author
-
Tom Jackson, Reza Razavi, Jonathan M. Behar, Angela W.C. Lee, Zhong Chen, C. Aldo Rinaldi, Frits W. Prinzen, Eoin R. Hyde, Anoop Shetty, Simon Claridge, Steven A. Niederer, Julian Bostock, Manav Sohal, Fysiologie, and RS: CARIM - R2 - Cardiac function and failure
- Subjects
Male ,medicine.medical_specialty ,Haemodynamic response ,medicine.medical_treatment ,Bundle-Branch Block ,Cardiac resynchronization therapy ,Hemodynamics ,Acute hemodynamic response ,Ventricular Function, Left ,Cohort Studies ,Physiology (medical) ,Internal medicine ,Humans ,Medicine ,Cardiac Resynchronization Therapy Devices ,Aged ,Heart Failure ,Bundle branch block ,business.industry ,Left bundle branch block ,Middle Aged ,medicine.disease ,Defibrillators, Implantable ,Treatment Outcome ,medicine.anatomical_structure ,Multisite pacing ,Ventricle ,Heart failure ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Noncontact mapping - Abstract
Multisite pacing (MSP) of the left ventricle is proposed as an alternative to conventional single-site LV pacing in cardiac resynchronization therapy (CRT). Reports on the benefits of MSP have been conflicting. A paradigm whereby not all patients derive benefit from MSP is emerging.We sought to compare the hemodynamic and electrical effects of MSP with the aim of identifying a subgroup of patients more likely to derive benefit from MSP.Sixteen patients with implanted CRT systems incorporating a quadripolar LV pacing lead were studied. Invasive hemodynamic and electroanatomic assessment was performed during the following rhythms: baseline (non-CRT); biventricular (BIV) pacing delivered via the implanted CRT system (BIV(implanted)); BIV pacing delivered via an alternative temporary LV lead (BIV(alternative)); dual-vein MSP delivered via 2 LV leads; MultiPoint Pacing delivered via 2 vectors of the quadripolar LV lead.Seven patients had an acute hemodynamic response (AHR) of10% over baseline rhythm with BIV(implanted) and were deemed nonresponders. AHR in responders vs nonresponders was 21.4% ± 10.4% vs 2.0% ± 5.2% (P.001). In responders, neither form of MSP provided incremental hemodynamic benefit over BIV(implanted). Dual-vein MSP (8.8% ± 5.7%; P = .036 vs BIV(implanted)) and MultiPoint Pacing (10.0% ± 12.2%; P = .064 vs BIV(implanted)) both improved AHR in nonresponders. Seven of 9 responders to BIV(implanted) had LV endocardial activation characterized by a functional line of block during intrinsic rhythm that was abolished with BIV pacing. All these patients met strict criteria for left bundle branch block (LBBB). No nonresponders exhibited this line of block or met strict criteria for LBBB.Patients not meeting strict criteria for LBBB appear most likely to derive benefit from MSP.
- Published
- 2015